HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Roux Selected Research

strontium ranelate (protelos)

3/2012Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis.
10/2009Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis.
9/2009Spinal deformity index (SDI) is a good predictor of incident vertebral fractures.
12/2008Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis.
7/2008Strontium ranelate: short- and long-term benefits for post-menopausal women with osteoporosis.
4/2008Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis.
3/2008Effects of strontium ranelate on spinal osteoarthritis progression.
12/2007Mild prevalent and incident vertebral fractures are risk factors for new fractures.
12/2002Prevention of early postmenopausal bone loss by strontium ranelate: the randomized, two-year, double-masked, dose-ranging, placebo-controlled PREVOS trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Roux Research Topics

Disease

37Osteoporosis
03/2019 - 01/2000
16Postmenopausal Osteoporosis
12/2015 - 01/2000
8Bone Resorption
05/2017 - 02/2000
5Rheumatoid Arthritis
10/2018 - 11/2004
4Neoplasms (Cancer)
01/2021 - 09/2011
4Spondylarthropathies
01/2017 - 11/2002
4Necrosis
09/2015 - 04/2003
3Inflammation (Inflammations)
12/2017 - 02/2011
3Wounds and Injuries (Trauma)
07/2014 - 12/2001
3Hip Fractures (Intertrochanteric Fractures)
06/2014 - 01/2000
3Infections
01/2012 - 11/2003
3Back Pain (Backache)
10/2009 - 03/2008
2Body Weight (Weight, Body)
06/2022 - 08/2005
2Weight Loss (Weight Reduction)
06/2022 - 05/2008
2Hypophosphatasia
05/2017 - 03/2016
2Osteoarthritis
09/2015 - 01/2011
2Metabolic Bone Diseases (Osteopenia)
10/2001 - 02/2001
1Osteoporotic Fractures
06/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2021
1Lung Diseases (Lung Disease)
01/2021
1Anorexia Nervosa
03/2019
1Primary Hyperparathyroidism
03/2019
1Adrenocortical Hyperfunction (Adrenal Gland Hyperfunction)
03/2019
1Alcoholism (Alcohol Abuse)
03/2019
1Psoriasis (Pustulosis Palmaris et Plantaris)
02/2019
1Skin Diseases (Skin Disease)
02/2019
1Acne Vulgaris
02/2019
1Agammaglobulinemia (Hypogammaglobulinemia)
10/2018
1Leukemia
05/2017
1Joint Diseases (Joint Disease)
05/2017
1Central Nervous System Diseases (CNS Diseases)
01/2017
1Obesity
01/2017
1Chronic Renal Insufficiency
01/2017
1Pain (Aches)
09/2015
1Axial Spondyloarthritis
05/2015
1Paraganglioma (Paragangliomas)
10/2014
1Hypertension (High Blood Pressure)
10/2014
1Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2014
1Pheochromocytoma
10/2014
1Thromboembolism
05/2014
1Vitamin D Deficiency
05/2014
1Myocardial Infarction
05/2014
1Heart Arrest (Cardiac Arrest)
05/2014
1Stroke (Strokes)
05/2014
1Atrial Fibrillation
05/2014
1Mycoses (Diseases, Fungus)
12/2013

Drug/Important Bio-Agent (IBA)

9strontium ranelate (protelos)IBA
03/2012 - 12/2002
7GlucocorticoidsIBA
03/2019 - 01/2002
6Vitamin DFDA LinkGeneric
06/2022 - 05/2002
6Biomarkers (Surrogate Marker)IBA
12/2017 - 02/2000
5Diphosphonates (Bisphosphonates)IBA
05/2013 - 01/2000
5Risedronic Acid (Actonel)FDA LinkGeneric
01/2013 - 01/2000
4Adrenal Cortex Hormones (Corticosteroids)IBA
01/2017 - 10/2000
4Alkaline PhosphataseIBA
03/2016 - 02/2000
4Infliximab (Remicade)FDA Link
03/2008 - 11/2002
3CalciumIBA
06/2022 - 05/2002
3DenosumabFDA Link
12/2015 - 01/2012
3Adalimumab (Humira)FDA Link
09/2015 - 11/2004
3ElementsIBA
01/2015 - 02/2000
3Biological ProductsIBA
09/2011 - 12/2001
3Collagen Type I (Type I Collagen)IBA
03/2008 - 02/2000
2Aromatase InhibitorsIBA
03/2019 - 01/2017
2N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA
05/2017 - 03/2016
2MineralsIBA
01/2017 - 07/2001
2Pharmaceutical PreparationsIBA
11/2014 - 03/2008
2Parathyroid Hormone (Parathormone)IBA
05/2013 - 02/2009
2Etanercept (Enbrel)FDA Link
02/2013 - 11/2004
2Testosterone (Sustanon)FDA Link
05/2008 - 01/2001
2Hormones (Hormone)IBA
05/2008 - 08/2002
2CytokinesIBA
05/2008 - 03/2008
2Insulin-Like Growth Factor I (IGF-1)IBA
05/2008 - 08/2005
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2008 - 08/2005
2SteroidsIBA
04/2006 - 06/2003
2Alendronate (Alendronate Sodium)FDA LinkGeneric
11/2002 - 02/2000
2CholesterolIBA
02/2001 - 04/2000
1AdipokinesIBA
02/2019
1ParaffinIBA
02/2019
1Formaldehyde (Formol)FDA Link
02/2019
1Methotrexate (Mexate)FDA LinkGeneric
10/2018
1Rituximab (Mabthera)FDA Link
10/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018
1Proteins (Proteins, Gene)FDA Link
01/2018
1Heparin (Liquaemin)FDA LinkGeneric
11/2017
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
09/2015
1Analgesics (Analgesic Drugs)IBA
09/2015
1C-Reactive ProteinIBA
05/2015
1Sunitinib (Sutent)FDA Link
10/2014
1Caspase 3 (Caspase-3)IBA
10/2014
1CatecholaminesIBA
10/2014
1Sorafenib (BAY 43-9006)FDA Link
10/2014
1Glutamic Acid (Glutamate)FDA Link
07/2014
1N-Methylaspartate (NMDA)IBA
07/2014
1Alemtuzumab (Campath)FDA Link
12/2013

Therapy/Procedure

17Therapeutics
06/2022 - 01/2000
2Radiotherapy
10/2021 - 09/2011
1Radiofrequency Ablation
01/2021
1Length of Stay
01/2021
1Hematopoietic Stem Cell Transplantation
05/2017
1Patient Readmission
05/2014
1Perioperative Period
05/2014